Demonstrating Draganfly's Vital IntelligenceBy repealing the requirement to wear masks when using public means of transportation previously mandated by the US government, the US federal court system set forth a dynamic that potentially exposes US residents to COVID-19 infections. Nonetheless, Draganfly (NASDAQ: DPRO) is equipped with biomedical tech innovations that can be used to mitigate and manage the above risk. The above firm is set to participate at the Seatrade Cruise Global 2022, to exhibit its biomedical tech "Vital Intelligence" to demonstrate its utility and value in the nation’s social interaction context.